Claire Snyder, PhD; Michael Brundage, MD MSc; and Norah Crossnohere, PhD
PROTEUS Leadership

Patients, clinicians, health system administrators, regulators, and policy makers value information regarding the impact of disease and treatment from the perspective of patients. Patient-reported outcome (PRO) assessments have, therefore, become critical endpoints assessed in research studies and are increasingly integrated into clinical care to monitor patients and inform their management. However, PROs can only be used effectively if they are measured appropriately and reported clearly. Methodologic tools have been developed by ISOQOL and others to improve the assessment and interpretation of PROs in research studies (particularly clinical trials and comparative effectiveness studies) and in clinical practice.

To ensure that patients, clinicians, and other decision-makers have PRO data to make the best decisions they can about treatment options, the PROTEUS Consortium (Patient-Reported Outcomes Tools: Engaging Users & Stakeholders) is partnering with 37 key patient, clinician, research, health system, funding, and regulatory groups from the U.S. and internationally, including ISOQOL. PROTEUS’s most immediate function is to disseminate and facilitate use of the methodologic resources and materials through direct engagement with stakeholders and through its website (

These are the trials-related core methodologic tools:1

  • SPIRIT-PRO Guidance2 for writing PRO aspects of protocols
  • ISOQOL Minimum Standards for PRO Measures in PCOR/CER3 to inform PRO measure selection
  • SISAQOL Consortium Guidance4 for analyzing PRO data
  • CONSORT PRO Guidance5 and Stakeholder-Driven, Evidence-Based Standards for Presenting PROs in Clinical Practice6 for reporting PRO findings
  • Clinician’s Checklist for Reading and Using an Article About PROs7 for interpreting PRO papers

PROTEUS has also developed guidance for including and reviewing PRO endpoints in grant applications.8

These are the practice-related core methodologic tools:

  • ISOQOL Users Guide for Implementing PRO Assessment in Clinical Practice9 step-by-step guide to the considerations involved in, and options for, implementing PROs in routine care
  • User’s Guide for Integrating Patient-Reported Outcomes in Electronic Health Records10 step-by-step guide to the considerations involved in, and options for, integrating PROs in electronic health records
  • Stakeholder-Driven, Evidence-Based Standards for Presenting PROs in Clinical Practice6 recommendations for displaying PRO data to promote understanding and use
  • Medical Care Supplement “A PRO-cision Medicine Methods Toolkit”11 a range of approaches for interpreting and acting on PRO data in clinical practice
  • ePROs in Clinical Care12 website aimed at helping health systems with PRO intervention design

In addition to providing links to the above tools, the PROTEUS website provides checklists, templates, brief web tutorials, handbooks, and other resources to help navigate the use of PROs in clinical trials and clinical practice. We invite you to visit frequently as we are constantly adding information and resources. You can also join the mailing list for our bimonthly newsletter, PRO-cisely PROTEUS, on the website.

To view our references, please click the button below.

Support: PROTEUS has received funding from the Patient-Centered Outcomes Research Institute and unrestricted grants from Genentech and Pfizer.

This newsletter editorial represents the views of the author and does not necessarily reflect the views of ISOQOL. 

How to Submit a Newsletter Editorial
Do you have something to share about health related quality of life and patient-centered outcomes? We want to hear from you!
Learn More

The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health related quality of life research (HRQL).

Together, we are creating a future in which patient perspective is integral to health research, care and policy.